Applications and regulatory of nanotechnology‐based innovative in vitro diagnostics

Abstract

Abstract Nanotechnology‐basedin vitro diagnostics (nanoIVDs) are widely studied for disease diagnostics with promising sensitivity, specificity, and convenience. However, it is still a major challenge for both regulatory authorities and scientific researchers to accelerate the clinical translation of such an innovative technology. Herein, this perspective discussed the benefits and challenges of nanoIVDs as well as the administration considerations on the distinguish features of nanoIVDs by regulatory authorities, so as to further achieve the evaluation, translation, and application of nanoIVD products.

Keywords

• COVID‐19 (SARS‐CoV‐2) detection
• in vitro diagnostics (IVD)
• nanomaterials
• nanotechnology‐based in vitro diagnostics (nanoIVDs)
• regulatory science